1887
Volume 2012, Issue 2
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

To determine the prevalence of eclampsia in Qatar, the associated maternal and perinatal outcomes for the period from January 1991 to December 2009 and to define any possible preventive measures to this potentially fatal complication. A retrospective case review was performed of all women with eclampsia admitted to the Women's Hospital and Obstetrics and Gynecology department at Al Khor Hospital for the period from January 1991 to December 2009. Details were collected by reviewing the files of the patients from the medical records. Data were analyzed by either X2 analysis or the unpaired student “t” test as appropriate. During the period of the study there were 224,809 births. Seventy women developed eclampsia (0.31/1000 deliveries), 44.3% of them were antepartum, 31.4% postpartum and 24.3% intrapartum eclampsia. 34.3% of patients presented with fits, 38.5% presented with pre-eclampsia (PE) and 20% presented with severe pre eclampsia; 18.5% were mild PE and another 27.2% were admitted with different complaints. Symptoms of impending eclampsia were seen in 22.9% of the PE patients. Thirty percent had no antenatal care (ANC). Antihypertensive therapy was given to 72% of cases. Antiepileptic therapy was administered to 48% of cases and 58.5% received magnesium sulfate. Eclampsia was associated with increased rate of cesarean section (CS) (64.2%). There was one maternal death, and the rate of major maternal complications was 20%. The perinatal mortality rate was 12.8%. The incidence of eclampsia in Qatar is 0.31 per 1000 deliveries. Although rare, this condition is associated with increased maternal morbidity and perinatal mortality. However our result is lower than reported worldwide. Improvement of obstetric care by having high index of suspicion even with apparently low risk patients, using magnesium sulfate prophylaxis for all cases of severe pre-eclampsia, in addition to community based approach to improve community health, education and prenatal care, all can be effective measures for the decrease incidence of this fatal condition although eclampsia cannot be entirely prevented.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2012.2.6
2013-11-01
2019-08-18
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2012/2/qmj.2012.2.6.html?itemId=/content/journals/10.5339/qmj.2012.2.6&mimeType=html&fmt=ahah

References

  1. [1]. Department of health, Welsh Office, Scotish home and health department, Department of health and Social services Northern Ireland . Why Mothers die. Report on Confidential Enquiry into maternal deaths in the United Kingdom. 1997-1999 . London: : HMSO;   2000; .
    [Google Scholar]
  2. [2]. Rochat   RW., , Koonin   LM., , Atrash   HK., , Jewett   JF. . Maternal mortality in the /United states: report from the maternal mortality collaborative. . Obstet Gynecol . 1988; ;72: 1 : 91– 97 .
    [Google Scholar]
  3. [3]. Duley   L. . Maternal Mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America & the Caibbean. . Br J Obstet Gynaecol . 1992; ;99: 7 : 547– 553 .
    [Google Scholar]
  4. [4]. Cowther   C. . Magnesium Sulphate versus diazepam in the management of eclampsia: A randomized controlled trial. . Br J Obstet Gynaecol . 1990; ;97: : 110– 117 .
    [Google Scholar]
  5. [5]. Douglas   KA., , Redman   CW. . Eclampsia in the United Kingdom. . BMJ . 1994; ;309: : 1395 .
    [Google Scholar]
  6. [6]. Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. . Am J Obstet Gynecol . 1988; ;158: : 80– 83 .
    [Google Scholar]
  7. [7]. Morriss   MC., , Twickler   DM., , Hatab   MR., , Clarke   GD., , Peshock   RM., , Cunningham   FG. . Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia. . Obstet Gynecol . 1997; ;89: 4 : 561– 568 .
    [Google Scholar]
  8. [8]. Belfort   MA., , Moise   KJ Jr. . Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. . Am J Obstet Gynecol . 1992; ;167: 3 : 661– 666 .
    [Google Scholar]
  9. [9]. Lee   W., , O'Connell   CM., , Baskett   TF. . Maternal & Perinatal Outcomes of Eclampsia: Nova Scotia 1981-2000. . J Obstet Gynecol Can . 2004; ;26: 2 : 119– 123 .
    [Google Scholar]
  10. [10]. El Nafaty   AU., , Melah   GS., , Massa   AA., , Audu   BM., , Nelda   M. . The analysis of eclamptic Morbidity and Mortality in the Specialist Hospital Gombe, Nigeria. . J Obstet gynaecol . 2004; ;24: 2 : 142– 147 .
    [Google Scholar]
  11. [11]. Rasaly   S., , Carson-Dewitt. . Pre-eclampsia & eclampsia. . Gale Encyclopedia of Medicine . 23– 40 .
    [Google Scholar]
  12. [12]. Warden M & Euerle B. Pre eclampsia (Toxaemia of pregnancy) emergency Medicine 2003, Updated on April 5 2002 .
  13. [13]. On Wuhafua .
  14. [14]. Working group report on high blood pressure in pregnancy . Washington, DC: : National Institutes of Health;   2000; .
    [Google Scholar]
  15. [15]. Lewingston   S., , Clarke   R., , Qizilbash   N. , et al. , Age specific relevance of usual blood pressure on stroke risk:a prospective observational study. . Am J Epidemiol . 1995; ;142: : 1279 .
    [Google Scholar]
  16. [16]. Sibai   BM. . Treatment of hypertension in pregnant women. . N Engl J Med . 1996; ;335: : 257 .
    [Google Scholar]
  17. [17]. Von Dadelszen   P., , Ornstein   MP., , Bull   SB. , et al. , Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. . Lancet . 2000; ;355: : 87 .
    [Google Scholar]
  18. [18]. Magee   LA., , Ornstein   MP., , von Dadelszen   P. . Fortnightly review: management of hypertension in pregnancy. . BMJ . 1999; ;318: : 1332 .
    [Google Scholar]
  19. [19]. Coetzee   EJ., , Dommisse   J., , Anthony   T. . A randomized controlled trial of intravenous magnesium sulhate versus placenbo in the management of women with severe pre eclampsia. . Br J Obstet Gynaecol . 1998; ;105: : 300 .
    [Google Scholar]
  20. [20]. Alexander   JM., , Bloom   SL., , McIntire   DD., , Leveno   KJ. . Severe preeclampsia and the very low birth weight infant: is induction of labor harmful?.   Obstet Gynecol . 1999; ;93: : 485 .
    [Google Scholar]
  21. [21]. Nassar   AH., , Adra   AM., , Chakhtoura   N., , Gómez-Marín   O., , Beydoun   S. . Severe preeclampsia remote from term: labor induction or elective cesarean delivery?.   Am J Obstet Gynecol . 1998; ;179: 5 : 1210– 1213 .
    [Google Scholar]
  22. [22]. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. . Lancet . 1995; ;345: : 1455– 1463 .
    [Google Scholar]
  23. [23]. Duley   L., , Henderson-Smart   D. . Magnesium sulphate versus diazepam for eclampsia . (Cochrane Library, issue 3, 2001.Oxford: update software) .
    [Google Scholar]
  24. [24]. Duley   L., , Henderson-Smart   D. . Magnesium sulphate versus phenytoin for eclampsia . (Cochrane Review). In Cochrane Library, issue 3, 2001.Oxford: update software .
    [Google Scholar]
  25. [25]. Duley   L., , Henderson-Smart   D. . Magnesium sulphate versus diazepam for eclampsia. . Cochrane Database Syst Rev . 2003; ;   4 : CD000127 .
    [Google Scholar]
  26. [26]. Duley   L., , Henderson-Smart   D. . Magnesium sulphate versus phenytoin for eclampsia. . Cochrane Database Syst Rev . 2003; ;   4 : CD000128 .
    [Google Scholar]
  27. [27]. Sibai   BM. . Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. . Am J Obstet Gynecol . 1990; ;163: 3 : 1049– 1054 .
    [Google Scholar]
  28. [28]. Conde-Agudelo   A., , Kafury-Goeta   AC. . Case-control study of risk factors for complicated eclampsia. . Obstet Gynecol . 1997; ;90: 2 : 172– 175 .
    [Google Scholar]
  29. [29]. López-Liera   M. . Main clinical types and subtypes of eclampsia. . Am J Obstet Gynecol . 1992; ;166: 1 Pt 1 : 4– 9 .
    [Google Scholar]
  30. [30]. Sheehan   HL., , Lynch   JB. . Pathology of toxaemia of pregnancy . Baltimore: : Williams &Wilkins;   1973; .
    [Google Scholar]
  31. [31]. Robert   JM., , Villar   J., , Aruikumaran   S. . Peventing & treating eclamptic seizures. . BMJ . 2002; ;325: : 609 .
    [Google Scholar]
  32. [32]. Diagnosis and management of preeclampsia and eclampsia. ACOG practice bulletin #33, American College of Obstetricians and Gynecologists, January 2002 .
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2012.2.6
Loading
/content/journals/10.5339/qmj.2012.2.6
Loading

Data & Media loading...

Supplementary File 1

  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error